Abstract
INTRODUCTION
The hereditary connective tissue disease Loeys-Dietz syndrome (LDS) was first described in 2005 [1] , in 10 families with a phenotype of cardiovascular, craniofacial, neurocognitive and skeletal abnormalities associated with mutations in the genes encoding transforming growth factor b receptor 1 and 2 (TGFBR1 and TGFBR2). Today 5 types of LDS have been listed in OMIM (Online Mendelian Inheritance in Man, https://omim.org/) [2] [3] [4] [5] (Table 1) . Aneurysms and dissections in the aorta, as well as in other large arteries, are common in all types of LDS. American guidelines from 2010 recommend prophylactic surgery of the ascending aorta at a diameter > _4.2 cm in adult patients with LDS1 and LDS2 [6] . European guidelines from 2014 [7] repeat this threshold but state that this is based on early experience with LDS1 and LDS2 in patients with aggressive vasculopathy [8] and suggest that further investigation is needed. For LDS3 (SMAD3 mutation), which in the European guidelines is called aneurysmosteoarthritis syndrome, the guidelines state that there is no current consensus on management. A review article published in 2014 [9] gives comprehensive guidelines for the care of patients with LDS. For LDS1, LDS2 and LDS3 recommended surgical threshold in the aortic root was 4.0 cm, in the descending thoracic aorta 4.5-5.0 cm and in the abdominal aorta 4.0-4.5 cm. For LDS4, guidelines were not given, and LDS5 had not yet been described. Responding to this, other authors argued that applying the same guidelines to all patients with LDS defined as mutations in all genes involved in TGF-b signalling could lead to improper medical and surgical treatment [10] . In a recent publication, aortic root thresholds of 4.0 cm is recommended for LDS1 and 2, 4.0-4.5 cm for LDS3 and 4.5 cm for LDS4 and 5 [11] . Another recent multicentre publication reporting 441 patients with TGFBR1 and TGFBR2 mutations recommend 4.5 cm threshold for prophylactic root surgery [12] .
It is of value that experience with the natural course and treatment of this disease is shared in the medical community, so that evidence can be built to support recommendations.
MATERIALS AND METHODS
We retrospectively reviewed all patients with confirmed LDS1-4 mutations undergoing cardiovascular surgery during the years 1991-2016 in our department in the regional hospital covering the South-East Health region of Norway with 2.8 million inhabitants. We did not include surgery for other indications associated with the syndrome, like chest or spine deformities, hernias and so on. Also catheter-based interventions like ablations, pacemaker devices and interventional radiology have not been included. Operations before 2005 were included if the patients were given the LDS diagnosis in 2005 or later. Two patients had their first operation at another institution before being operated at our department, and these are included. Before 2005, some of the patients were clinically diagnosed with Marfan syndrome (MFS), and some had an unspecified diagnosis of hereditary connective tissue disease. Since 2005 our Department of Medical Genetics was offering Sanger sequencing analysis of the genes associated with LDS1 and LDS2, and in the year 2013, high-throughput sequencing analysis was introduced, notably exome sequencing with bioinformatic filtering of a panel of 33 genes associated with connective tissue diseases including LDS1-4. In 2016, the panel was expanded to 44 genes including the gene for LDS5, but LDS5 is not included in our material.
Prophylactic surgery has been performed according to guidelines but also considering patient preference based on individual family history with fatal aortic emergencies in young age. Adult patients are followed in our department with echocardiography and regular magnetic resonance imaging or computed tomography angiography imaging of the head, neck, chest and abdomen. Most of them are treated with beta-blockers. Children (<18 years) are followed by paediatric cardiologists.
The study was approved by the institutional review board, and individual consent was waved.
Statistical methods
Comparisons were done with Kruskal-Wallis test and Fisher's exact test. Survival and freedom from reintervention were calculated with Kaplan-Meier analyses (IBM SPSS Statistics 22).
RESULTS
Thirty-five patients with presumed pathogenic LDS1-4 mutations from 16 families underwent 57 cardiovascular operations during the years 1991-2016, 17 were women (49%), and 6 were children (17%). From 12 of these families, 23 relatives (age 4-53 years) who underwent predictive genetic testing with positive result are included in a surveillance programme, of whom 4 aged 20-27 years are scheduled for prophylactic surgery for aortic root dilatation. Table 2 shows the distribution of patients in LDS types 1-4. In the family histories of the 16 families, 21 sudden deaths are reported at ages between 26 and 60 years. Some of these happened before 1991. In our department, we have no medical records confirming time and cause of death. Phenotype variations within families were observed. In one family, 3 children were operated for aortic root dilatation, while other family members had their first operation at ages 58 and 65 years.
Age at first surgery
Mean age at first surgery was 36 years, median 37 years, range 2-65 years. For patients with LDS1, mean age at first surgery was 36 years, and for LDS2, LDS3 and LDS4, it was 29, 45 and 42 years, respectively (P = 0.052, Kruskal-Wallis test).
There were 6 children aged 2-16 years from 3 families in the LDS2 group and no children operated in the other LDS types. The 2-year-old child was operated in 1993 for atrial septal defect. In 2 LDS3 families, all patients were well above 50 years at first surgery. However, in a third LDS3 family, 1 patient was first operated at the age of 39, but 2 persons (twins) aged 27 years with a root diameter 4.3 cm are scheduled for surgery, and there is family history of death at age 26 from aortic dissection.
Emergency surgery
Of the 35 patients, 8 had their first surgery as an emergency (Tables 3 and 4) . One patient had ruptured abdominal aortic aneurysm in pregnancy. This patient also suffered Stanford type A dissection 2 years later. One patient had ruptured ascending aortic aneurysm (child), and 6 others had Stanford type A aortic dissections. Four of these emergencies (in 3 patients, 2 families) LDS1  OMIM#609192  TGFBR1  LDS2  OMIM#610168  TGFBR2  LDS3  OMIM#613795  SMAD3  LDS4  OMIM#614816  TGFB2  LDS5 OMIM#615582 TGFB3 Four of the patients (5 emergencies) were LDS2, while 2, 1, and 1 patients were LDS1, 3, and 4, respectively. After 9 emergency surgeries, there was 1 postoperative death in a 35-year-old with LDS2 and type A dissection. This patient had a family history suspect of MFS, and LDS was not diagnosed when the patient was admitted in 2005 with dissection and abdominal malperfusion and died on Day 47 due to multiorgan failure. Of the other 7 patients undergoing 8 emergency surgeries, 6 are alive and 3 required additional surgical procedures during follow-up. One late death was caused by drug overdose.
We have CT scans with diameter measures at the day of dissection for 4 patients with type A dissection. The LDS2 patient who died had a root diameter of 3.6 cm, and the diameter was 5.1, 6.0 and 4.9 cm in LDS1, 3 and 4, respectively. In 4 of the 7 type A dissections, the disease was limited to the ascending aorta, but 2 of these still needed additional surgery.
Prophylactic surgery for aortic root dilatation
Prophylactic surgery for dilated aortic root was performed in 22 patients; 17 with VSRR (1 Yacoub and 16 David procedures) and 5 with root replacement with mechanical-valved conduit.
The prophylactic VSRRs were performed during the years 2003-2016; 8 in patients with LDS2 (3 children), 7 in LDS3 and 2 in LDS4. Root diameter when VSRR was performed was median 4.6 cm (range 3.6-6.0). One patient was reoperated 7 months after VSRR with prosthetic aortic valve replacement. One patient died on Day 14 after VSRR and mitral valve plasty (MVP). One patient suffered type B aortic dissection 6 years after VSRR and needed Elephant Trunk I and II procedures, but the VSRR itself is functioning well. Figure 1 shows that freedom from aortic root reintervention and death was 92% at 13 years for the 16 surviving patients operated with VSRR. Nine patients had more than 8 years of follow-up.
The mechanical valve conduits were performed during 1992-2006 in 3 patients with LDS2 (1 child), and 1 patient in each of LDS1 and 3. Two patients treated with prosthetic conduit needed additional vascular surgery for abdominal aneurysm and so on, and 1 died 24 years after surgery (Tables 3 and 4) .
Mitral valve disease
In 3 of the 5 families with LDS3, 5 patients needed mitral valve repair (MVP, n = 4) or replacement (MVR, n = 1), either alone (n = 2) or combined with VSRR (n = 3). The only postoperative death after all 48 elective procedures was a 40-year-old patient operated with VSRR and MVP who needed postoperative extracorporeal membrane oxygenation treatment but died of heart failure. Preoperatively he had left ventricle dilatation to 9 cm, severe mitral regurgitation with prolapse and ruptured chordae. All 5 patients undergoing mitral surgery had mitral prolapse, 3 had ruptured chordae, and in 2 patients, mitral annular disjunction was described. Two patients had arrhythmia problems. One patient with mitral annular disjunction, operated with MVP in 2011, now has recurrent regurgitation, and the aortic root, which was normal in 2011, now measures 4.2 cm. He is considered for redo surgery. We have not seen mitral valve disease in LDS1, LDS2 and LDS4. 
Additional surgery
A total of 57 cardiovascular operations were performed in 35 patients, with a mean 1.6 operations/patient (Tables 3 and 4) . Of the 57 operations, 33 were surgeries on the ascending aorta and arch and 24 were surgeries on other parts of the aorta (n = 15), other large arteries (n = 5) or isolated heart surgery (n = 4). Of the 20 operations on descending, thoraco-abdominal, abdominal aorta and arch/neck and iliac vessels, 16 were performed in patients with LDS2, 3 in LDS1 and 1 in LDS3. Eleven of these operations were performed for primary aneurysms, while 9 were for post-dissection aneurysms, mostly type A dissection, and in 1 case B-dissection occurring 6 years after prophylactic surgery of the aortic root. Mean age when these procedures were performed was 43 years, median 41, range 26-65 years. Twenty-five patients had 1 operation (Table 3) , while 10 patients had a median of 2.5, range 2-7 operations (Table 4) . Of the 10 patients with more than 1 operation, 6 had LDS2, and 2, 1, and 1 patient had LDS1, LDS3, and LDS4, respectively. There were 4 patients with > _4 operations. They all had LDS2, and 2 of them had disease progression related to pregnancy. Four of the 10 patients had suffered aortic dissection, while 4 of the 25 patients with only 1 operation had aortic dissection (P = 0.19, NS, Fisher's exact test). These 8 dissections were the 7 type A dissections formerly discussed and 1 type B dissection in LDS2, which occurred 6 years after prophylactic root repair in a 4-cm aorta. Patients with dissection had a mean of 2.6 operations, compared with 1.3 operations in patients without dissection.
In 4 patients, the index operation was for descending (n = 1), thoraco-abdominal (n = 2) and ruptured abdominal (n = 1) aneurysm without dissection. Three of these had LDS2, and 1 had LDS1. The index operation was isolated heart surgery in 3 patients. Two patients operated for mitral valve disease had LDS3, and 1 child operated for atrial septal defect had LDS2. The index operations were surgery of the ascending aorta in 28 of the 35 patients.
Survival
After a total of 57 operations in 35 patients, there were 2 postoperative deaths. A 35-year-old with LDS2 died due to multiorgan failure on Day 47 after surgery for type A dissection, and a 40-year-old with LDS3 died due to heart failure 14 days after prophylactic surgery with VSRR and MVP. There were no postoperative strokes or spinal cord ischaemia, and no permanent renal failure. There were 2 late deaths, both in patients with LDS2. One person operated during childhood in 1992 died 24 years later after admittance to the local hospital with atrial fibrillation. After cardiac arrest, resuscitation was unsuccessful. Autopsy did not show bleeding. One person with LDS2 undergoing multiple surgeries from the age of 25 died 20 years after the first and 4 years after the last operation from a drug overdose. Mean follow-up time until death or until 31 December 2016 was 8.2 years, median 9.2 years, range 0-24 years. Figure 2 shows survival after the first operation for all 35 patients. Cumulative survival at 20 years was 94.3%.
DISCUSSION
When LDS was described in 2005 [1, 8] as a syndrome caused by mutations in TGFBR1 and TGFBR2, LDS1 and LDS2 were defined not by the mutations but by clinical features. Patients were assigned to LDS1 if they had typical findings of craniofacial involvement like cleft palate, craniosynostosis or hypertelorism implying a syndromic form, while patients with LDS2 did not have these findings. However, both LDS1 and LDS2 implied a great risk for aortic dissection and rupture at young age.
As other gene mutations causing changes in TGF-b signalling were described [2] [3] [4] [5] , a new classification of LDS was suggested [9] , defining the types of LDS based on the mutated gene. This classification is controversial [10] . An alternative classification of heritable thoracic aortic aneurysm and dissection has been published [13, 14] , dividing the diseases into those with gene mutations affecting extracellular matrix (FBN1, COL3A1, etc.), TGF-b signalling or vascular smooth muscle cell contractility (ACTA2, MYH11, etc.), insisting to reserve the LDS diagnosis to the specific phenotype described in the initial publication. So far, more than 30 heritable conditions are associated with thoracic aortic aneurysm and dissection. In our presentation, we have chosen to use the classification of LDS 1-5, as shown in Table 1 [5, 9] .
Following classifications, surgery thresholds have been published for the different types of LDS, and these are also controversial [9, 11, 12] . The John Hopkins group states that LDS1 and LDS2 are the more aggressive subtypes [11] and recommend root surgery threshold 4.0 cm for these, but 4.0-4.5 cm for LDS3, and 4.5 cm for LDS4 and LDS5. The Montalcino Aortic Consortium [12] recommends root surgery at 4.5 cm in patients with TGFBR1 and TGFBR2 mutations, with the exception of women with TGFBR2 mutation and severe extra-aortic features, where surgery might be considered at 4.0 cm. One of our adult LDS2 patients suffered dissection with an aortic root diameter of 3.6 cm, and diameters were 4.9-6.0 cm in other dissection patients with LDS1, 3 and 4. For prophylactic surgery, all patients with diameters below 4.2 cm were LDS2, including children, and all with diameters above 5.0 cm were LDS3 from 4 families, except 1 LDS1 patient. The numbers are small, but these observations might support a lower threshold for surgery in LDS2.
Age at first surgery was considerably lower in the initial description of LDS compared with our experience. In a report of 52 families [8] , mean age at death was 26 years. Mean age at first cardiovascular surgery was 19.8 years, 16.9 vs 26.9 years in LDS1 vs LDS2. In a recent report from the John Hopkins Medical Institutions [11] including 79 operated patients with LDS, mean age at first surgery was 25 years, but data on the various types of LDS were not given. In our material, mean age at first surgery was 36 years for LDS1-4, and 29 years for LDS2, while patients with LDS3 and 4 had their first surgery at a mean age >40 years, although with great variation in the LDS3 group, ranging from 30 to 58 years. We see a trend that debut of symptoms occur at a younger age in LDS2, and failure to reach statistical significant difference (P = 0.052) might be caused by small numbers. We had 17% children in the surgical population, all with LDS2, and from 3 different families. Also 6 of 10 patients who needed more than 1 operation, and all patients who needed more than 3 operations had LDS2. Sixteen of the 20 operations performed on the aorta and large vessels distal to the arch were in patients with LDS2. Thus, it seems like LDS2 is associated with a more aggressive vascular disease, with symptoms occurring at younger age, and with increased risk of disease in other segments than the ascending aorta. This might suggest that predictive genetic testing is particularly important in children in LDS2 families. Family histories in our LDS1, 3 and 4 patients report several vascular catastrophes, but none in children. Not all children in these families have been tested, but indication for surgery has not been found. Only 1 of the 11 LDS3 patients needed surgery for vascular disease outside the ascending aorta/arch. We have only 4 patients with LDS1, and 2 of them had surgery for thoraco-abdominal, abdominal and iliac aneurysms at the age of 27 and 59 years. However, the group is too small to draw any conclusions. As more experience and knowledge is gained, classifications and guidelines will need further revisions. In the future, there might also be additional prognostic information from the specific mutation within the gene [12] .
Another publication from the John Hopkins group describes surgical management of peripheral vascular manifestations in 18 patients with LDS undergoing 36 vascular operations [15] . 'Peripheral' was defined as descending thoracic aorta and more distal. The results were good, with 1 death after surgery for ruptured renal artery aneurysm. No information was given about the types of LDS, and surgical thresholds for treatment of different arteries were not discussed. Having suffered aortic dissection was not associated with the need for peripheral surgical repair. Also in our experience, having suffered aortic dissection does not seem to increase the risk for additional surgery. There was no difference in prevalence of dissection in the group with only 1 operation versus the group with several operations, but the numbers are small. More than 50% of the operations distal to the arch were performed for primary aneurysms, and prophylactic surgery of the aortic root will obviously not protect patients from these events. For MFS, it is generally accepted that prophylactic surgery to avoid type A dissection has been important to the increased life expectancy achieved during the last decades [16] . One might expect that this would be true also for patients with LDS, and as genetic testing is more widely available to the families, vascular catastrophes can be avoided by follow-up and timely prophylactic interventions. But there are still many questions in this area. We do not know the real incidence of vascular disease outside the ascending aorta nor whether this differs in the different types of LDS. At least for LDS2, it seems to be more common than in MFS. There is also lack of evidence for thresholds for surgery/intervention for these peripheral lesions and of information on short-and long-term results of treatment.
Five of 11 patients with LDS3, from 3 families, needed surgery for mitral valve regurgitation. In 2 patients, mitral annular disjunction was described, which may suggest involvement of the fibrous skeleton of the heart. Mitral valve anomalies were found in 50% of the patients in the initial presentation of the phenotypic spectrum of SMAD3-related aneurysms [3] and were also found in patients with LDS5 [5] . In a recent publication [11] , mitral valve surgery was done in 3 of the 79 patients, but the LDS types of these patients were not specified. In another publication [17] , mitral valve surgery was not performed in any of 71 patients with LDS2. As our experience is limited by small numbers, we have to wait for future publications to see whether it can be confirmed that LDS3 patients have an increased risk of severe mitral valve disease.
Several publications have reported excellent result of surgery in LDS [11, [18] [19] [20] [21] . Our results confirm this, with 94.3% cumulative survival 20 years after the index operation. Also, VSRR seems to be durable, although our experience with this procedure in LDS is limited, with 9 patients with a follow-up of more than 8 years. The clinical features of LDS overlap with the vascular type of EhlersDanlos syndrome, but the tissue is not as fragile, and standard surgical techniques can be used, with preference of single-vessel inclusions of arch and visceral branches. We have no experience with thoracic endovascular aortic repair in LDS, but we have experienced in MFS that thoracic endovascular aortic repair and hybrid surgery can be an alternative to treat patch aneurysms, where sealing zones are within a polyester prosthesis.
CONCLUSION
We have presented our experience with 57 cardiovascular operations in 35 patients with LDS 1-4, and based on these numbers a reliable comparison between the different types of LDS is not possible. Knowledge in the field of heritable aortic and vascular disease is rapidly expanding, but many questions and controversies remain. Experience of the natural history and results of treatment need to be shared, preferably in multicentre registries, to be able to develop better evidence-based counselling and treatment to patients with different types of LDS.
